
|Videos|December 16, 2021
Trial investigates negative predictive value of cystoscopic examinations in patients with bladder cancer
Author(s)Urology Times staff
"The problem is that we are not very good at predicting who is not harboring any cancer in their bladder,” says Alexander Kutikov, MD, FACS.
Advertisement
In this video, Alexander Kutikov, MD, FACS, discusses his presentation, “Can systematic bladder sampling predict pT0?” which was part of the bladder cancer course at the 2021 Society of Urologic Oncology Annual Meeting. Kutikov is the chief of the division of urology and urologic oncology, professor in the department of surgical oncology, and the Roberta R. Scheller Chair in urologic oncology at the Fox Chase Cancer Center at Temple University in Philadelphia, Pennsylvania.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants tentative approval to generic olaparib tablets across previously approved indications
2
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
3
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
4
Prof Declan Murphy on interpreting the PROTEUS trial in localized prostate cancer
5











